By Admin 
India pain reliafe market: The pain market in India is constantly increasing. In everyday life, people have started using pen killer tablets, sprays and creams to get rid of pain. Alam is that the market of pen resting medicines in India has reached Rs 16000 crore.
New brands are being launched every week
Nielsen has revealed in his report, quoting industry officials, in the last five years, the segment has risen by more than one billion dollars, which is at the forefront of the segment of without prescription drugs.
According to an ET report, on an average, five pen relief brands were launched almost every week after Corona. In 2020, the number of such brands was 1,552, including names like Volini, Omanigel, Dolo and Seridon. Now their number has increased to 2,771.
Talking to ET, the managing director of Cipla Health said, “People have started giving more priority to rest as soon as possible. In spite of the warnings of indiscriminate pen relief medicine to be dangerous for health, their demand is increasing.
Growing business of pen relief drugs
Especially the business of these drugs in cities is continuously increasing. The market cap of drugs such as analgesic and rubphensiants has often reached Rs 15,905 crore in May 2020 in May 2020 to Rs 15,905 crore in May 2025 due to the problem of gym injury or muscle stretch problem. That is, its annual growth rate is growing from 18 percent CAGR. Analgesic Pen Relief holds 75 percent stake in the category of drugs. Paracetamol also contributes more.
Sandeep Verma, the head of the consumer health business for South Asia in Bayer Pharmaceuticals, says, people in India believe that taking pen relief medicine is a sign of weakness or we are becoming very dependent on it. Kovid has taught us how stress, tiredness and small pain can also reduce our health and productivity.
Also read:
Prepare with money quickly, big updates about IPO; This company applied to SEBI